Australian Regulator Explains How To Comply With Advertising Rules While Meeting Continuous Disclosure Obligations

Companies should avoid focusing only on the positive qualities of a therapeutic good or omitting or downplaying the negative qualities such as possible side effects, according to new guidance on therapeutic goods advertising and Australian Securities Exchange announcements.

Chest of doctor wearing a white coat with hands around a heart-shaped Australian flag. — Australia's regulator has issue new guidance for companies that develop therapeutic goods • Source: Shutterstock

“Works fastest,” “the best,” and “life changing.” These are examples of the statements that Australia’s Therapeutic Goods Administration says health care product companies should avoid using if they want to comply with the requirements for advertising therapeutic goods when they make announcements to comply with their continuous disclosure obligations.

Listed and unlisted companies have continuous disclosure obligations under the Corporations Act 2001 to ensure market integrity and investor protection...